LAMISIL
As listed in the register: LAMISIL 250 mg COMPRIMIDOS
250 mg · comprimido
- Prescription only
- Skin
- Active substance
- Terbinafina
- Used in
- Skin
- Made by
- Novartis Farmaceutica S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria4 matching products
Canada7 matching products
Netherlands5 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Novartis Farmaceutica S.A. |
|---|---|
| Active substance | Terbinafina |
| Used in | Skin |
| Strength | 250 mg |
| Form | comprimido |
| Classification | D01BA02 · Skin |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Name in the register | LAMISIL 250 mg COMPRIMIDOS |
| Nº Registro | 59435 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.